Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Gil

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Journal of the American Heart Association|February 12, 2026
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by KlothoSara Vázquez-Sánchez, Ana Blasco, Marina Polo-Salguero, et al.
Cancers|November 25, 2023
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG SurveyHannah Woopen, Maren Keller, Dario Zocholl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA TrialJosep M Del Campo, Ursula A Matulonis, Susanne Malander, et al.
Biomolecules|January 23, 2024
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma ComorbiditiesSara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Frontiers in Genetics|November 18, 2024
An intragenic duplication in the AFF2 gene associated with Cornelia de Lange syndrome phenotypeCristina Lucia-Campos, Ilaria Parenti, Ana Latorre-Pellicer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2022
Clinical and genetic characteristics of Dent's disease type 1 in EuropeCarla Burballa, Gerard Cantero-Recasens, Larisa Prikhodina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Scientific Reports|July 30, 2021
Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in bloodAna Latorre-Pellicer, Marta Gil-Salvador, Ilaria Parenti, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Journal of the American Heart Association|February 12, 2026
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by KlothoSara Vázquez-Sánchez, Ana Blasco, Marina Polo-Salguero, et al.
Cancers|November 25, 2023
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG SurveyHannah Woopen, Maren Keller, Dario Zocholl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA TrialJosep M Del Campo, Ursula A Matulonis, Susanne Malander, et al.
Biomolecules|January 23, 2024
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma ComorbiditiesSara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Frontiers in Genetics|November 18, 2024
An intragenic duplication in the AFF2 gene associated with Cornelia de Lange syndrome phenotypeCristina Lucia-Campos, Ilaria Parenti, Ana Latorre-Pellicer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2022
Clinical and genetic characteristics of Dent's disease type 1 in EuropeCarla Burballa, Gerard Cantero-Recasens, Larisa Prikhodina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Scientific Reports|July 30, 2021
Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in bloodAna Latorre-Pellicer, Marta Gil-Salvador, Ilaria Parenti, et al.
Pageof 23